NBIX | Neurocrine Biosciences Inc
Neurocrine?s management team participates in industry conferences providing presentations on company updates and progress on research and development activities. The company conducts webcasts and conference calls for these conferences and provides financial highlights and company news updates during regularly scheduled conference calls. For questions or information on current or future webcasts and conference calls contact firstname.lastname@example.org. Webcast links and presentations will remain on this website for approximately 30 days or unless earlier replaced.
About the Company
Neurocrine Biosciences is a publicly traded biopharmaceutical company founded in 1992. The company is headquartered in San Diego, California, and led by CEO Kevin Gorman. Neurocrine develops treatments for neurological and endocrine-related diseases and disorders.
12780 El Camino Real
Videos about Neurocrine Biosciences Inc
If you are looking for News & events, Press Release, they are available on their Investors Relationssite.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
Buy on Amazon
Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.
The best book on investing ever written.